Infant Bacterial Therapeutics AB's total assets for Q1 2025 were kr207.92M, a decrease of -13.21% from the previous quarter. DE:9IB total liabilities were kr54.39M for the fiscal quarter, a -21.52% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.